Letter to Editor

Response to “Comment on: Association of SUVmax with Malignancy in Focal FDG-Avid Thyroid Incidentalomas”

Volume: 52 September 2, 2026
EN TR

Response to “Comment on: Association of SUVmax with Malignancy in Focal FDG-Avid Thyroid Incidentalomas”

Abstract

We read with interest the study by Öztürk et al. evaluating the performance of ultrasound risk stratification systems in focal FDG-avid thyroid incidentalomas. While TIRADS-based systems have shown high diagnostic performance, the SUVmax cut-off value and negative predictive value reported in their study closely align with our findings. This suggests that SUVmax offers consistent and complementary metabolic risk information across different centers. We believe that SUVmax and ultrasound-based risk stratification systems should not be seen as competing tools but rather as mutually supportive elements of a comprehensive clinical decision-making strategy.

Keywords

Details

Primary Language

English

Subjects

Endocrinology

Journal Section

Letter to Editor

Publication Date

September 2, 2026

Submission Date

July 22, 2026

Acceptance Date

July 23, 2026

Published in Issue

Year 2026 Volume: 52

APA
Öztop, H., Hunutlu, F. C., İşleyen Çolak, E., Bilgic, S., Şahin, A. B., & Öz Gül, Ö. (2026). Response to “Comment on: Association of SUVmax with Malignancy in Focal FDG-Avid Thyroid Incidentalomas”. Journal of Uludağ University Medical Faculty, 52. https://doi.org/10.32708/uutfd.2000899
AMA
1.Öztop H, Hunutlu FC, İşleyen Çolak E, Bilgic S, Şahin AB, Öz Gül Ö. Response to “Comment on: Association of SUVmax with Malignancy in Focal FDG-Avid Thyroid Incidentalomas.” Journal of Uludağ University Medical Faculty. 2026;52. doi:10.32708/uutfd.2000899
Chicago
Öztop, Hikmet, Fazıl Cagrı Hunutlu, Elif İşleyen Çolak, Seckin Bilgic, Ahmet Bilgehan Şahin, and Özen Öz Gül. 2026. “Response to ‘Comment On: Association of SUVmax With Malignancy in Focal FDG-Avid Thyroid Incidentalomas’”. Journal of Uludağ University Medical Faculty 52 (September). https://doi.org/10.32708/uutfd.2000899.
EndNote
Öztop H, Hunutlu FC, İşleyen Çolak E, Bilgic S, Şahin AB, Öz Gül Ö (September 1, 2026) Response to “Comment on: Association of SUVmax with Malignancy in Focal FDG-Avid Thyroid Incidentalomas”. Journal of Uludağ University Medical Faculty 52
IEEE
[1]H. Öztop, F. C. Hunutlu, E. İşleyen Çolak, S. Bilgic, A. B. Şahin, and Ö. Öz Gül, “Response to ‘Comment on: Association of SUVmax with Malignancy in Focal FDG-Avid Thyroid Incidentalomas’”, Journal of Uludağ University Medical Faculty, vol. 52, Sept. 2026, doi: 10.32708/uutfd.2000899.
ISNAD
Öztop, Hikmet - Hunutlu, Fazıl Cagrı - İşleyen Çolak, Elif - Bilgic, Seckin - Şahin, Ahmet Bilgehan - Öz Gül, Özen. “Response to ‘Comment On: Association of SUVmax With Malignancy in Focal FDG-Avid Thyroid Incidentalomas’”. Journal of Uludağ University Medical Faculty 52 (September 1, 2026). https://doi.org/10.32708/uutfd.2000899.
JAMA
1.Öztop H, Hunutlu FC, İşleyen Çolak E, Bilgic S, Şahin AB, Öz Gül Ö. Response to “Comment on: Association of SUVmax with Malignancy in Focal FDG-Avid Thyroid Incidentalomas”. Journal of Uludağ University Medical Faculty. 2026;52. doi:10.32708/uutfd.2000899.
MLA
Öztop, Hikmet, et al. “Response to ‘Comment On: Association of SUVmax With Malignancy in Focal FDG-Avid Thyroid Incidentalomas’”. Journal of Uludağ University Medical Faculty, vol. 52, Sept. 2026, doi:10.32708/uutfd.2000899.
Vancouver
1.Hikmet Öztop, Fazıl Cagrı Hunutlu, Elif İşleyen Çolak, Seckin Bilgic, Ahmet Bilgehan Şahin, Özen Öz Gül. Response to “Comment on: Association of SUVmax with Malignancy in Focal FDG-Avid Thyroid Incidentalomas”. Journal of Uludağ University Medical Faculty. 2026 Sep. 1;52. doi:10.32708/uutfd.2000899

ISSN: 1300-414X, e-ISSN: 2645-9027

Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
2023